martes, 2 de junio de 2026

Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns The late-stage trial has been closely watched

https://www.statnews.com/2026/06/01/abivax-ulcerative-colitis-obefazimod/ By Elaine ChenJune 1, 2026 Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.

No hay comentarios:

Publicar un comentario